deamidation comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-09-11. Where a claim depends on a specific study, the study is described rather than over-claimed.
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.
Storage recommendations for tirzepatide generally specify refrigeration at 2–8 °C to maintain stability. The peptide should be protected from light and kept in its original packaging to prevent aggregation or adsorption. Freezing is not recommended because freeze-thaw cycles can cause aggregation or precipitation. Once dispensed, storage conditions and in-use periods follow product-specific labeling, which may allow room temperature storage for a limited time.
Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Peptide backbone with a fatty diacid chain |
| Molecular weight | About 4813 Da | Calculated from the formula |
| Receptor targets | GIP and GLP-1 receptors | Dual agonist activity at both sites |
| Route of administration | Subcutaneous injection | No approved oral form at present |
| Elimination half-life | About 5 days | Supports extended intervals between administrations |
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
Recommended storage for reference material is a freezer at approximately -20 degrees Celsius, protected from light and moisture. Commercial injectable presentations are stored refrigerated between 2 and 8 degrees Celsius and must not be frozen. Product labelling generally permits a limited period at controlled room temperature once dispensed, with the exact window depending on the presentation. Repeated temperature cycling is avoided because it can promote aggregation or deamidation of the peptide chain.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, with mass confirmation by electrospray ionisation mass spectrometry. Peptide mapping after enzymatic digestion verifies the primary sequence. Size-exclusion chromatography quantifies aggregates, while circular dichroism provides a secondary-structure fingerprint. Bioanalytical quantification in plasma uses immunoassay or LC-MS/MS. Reported purity for research-grade lots is commonly 95 percent or higher, and residual water content is checked by Karl Fischer titration.
An abscess is a localized collection of pus which forms during an acute infection. The important difference between a periapical abscess and abscesses of the periodontium are that the latter do not arise from pulp necrosis. Abscesses of the periodontium are categorized as gingival abscess, periodontal abscess and pericoronal abscess. Combined periodontic-endodontic lesions may sometimes be abscesses, but these are considered in a separate category. A gingival abscess involves only the gingiva near the marginal gingiva or the interdental papilla. A periodontal abscess involves a greater dimension of the gum tissue, extending apically and adjacent to a periodontal pocket. A pericoronal abscess may occur during an acute episode of pericoronitis in the soft tissue surrounding the crown of a partially or fully erupted tooth, usually around a partially erupted and impacted mandibular third molar (lower wisdom tooth). Periodontal abscesses are the 3rd most common dental emergency, occurring either as acute exacerbation of untreated periodontitis, or as a complication of supportive periodontal therapy. Periodontal abscesses may also arise in the absence of periodontitis, caused by impaction of foreign bodies or root abnormalities.
14N, though also theoretically usable, has an integer nuclear spin of one and thus has a quadrupole moment that leads to wider and less useful spectra. 15N NMR nevertheless has complications not encountered in the more common 1H and 13C NMR spectroscopy. The low natural abundance of 15N (0.36%) significantly reduces sensitivity, a problem which is only exacerbated by its low gyromagnetic ratio, (only 10.14% that of 1H). As a result, the signal-to-noise ratio for 1H is about 300 times as much as that for 15N at the same magnetic field strength. This may be somewhat alleviated by isotopic enrichment of 15N by chemical exchange or fractional distillation. 15N-enriched compounds have the advantage that under standard conditions, they do not undergo chemical exchange of their nitrogen atoms with atmospheric nitrogen, unlike compounds with labelled hydrogen, carbon, and oxygen isotopes that must be kept away from the atmosphere. The 15N:14N ratio is commonly used in stable isotope analysis in the fields of geochemistry, hydrology, paleoclimatology and paleoceanography, where it is called δ15N. Of the thirteen other isotopes produced synthetically, ranging from 9N to 23N, 13N has a half-life of ten minutes and the remaining isotopes have half-lives less than eight seconds.
On July 5, 1932, to honor the memory of the recently deceased Dr. Llansó, the name was changed again to the Hogar Nacional Masónico Llansó (English: Llansó National Masonic Retirement Home), and its mission was changed from being a homeless shelter to that of a retirement home and hospice for the elderly.
where wt = Density of the wound area at time t ct = Density of the cell area at time t The above are basic metrics that can be measured with this assay. However efforts are still being made to improve the interpretation of this assay. Three different measurements: direct rate average, regression rate average and average distance regression rate have been evaluated. Direct rate average and average distance regression rate were more resistant to outliers, whereas regression rate average were more sensitive to outliers.
Sources: en.wikipedia.org
The Australian Defence Force currently supplies three different types of military ration packs – Combat Ration One Man, Combat Ration Five Man and Patrol Ration One Man. Combat Ration One Man is a complete 24-hour ration pack that provides two substantial meals per day and a wide variety of drinks and snacks for the remainder of the day. Most items, such as Beef Kai Si Ming, Dutch-style Beef with Vegetables, Beef with Spaghetti, Baked Beans, Sausages with Vegetables, or Chicken with pasta and vegetables, are packed in 250 gram sized plastic-foil retort pouches. Included with every meal pack is a pouch of instant rice or instant mashed potatoes, a fruit and grain bar, 2 envelopes of instant drink powder, some biscuits, an "Anzac Biscuit", a chocolate bar, M&M's, coffee, tea, sugar, crackers, cheese spread, jam, sweetened condensed milk, hard sweets, and Vegemite. It is packed in a tough clear polyethylene bag and weighs around 1.5–1.7 kg (3.3–3.7 lb). In practical use, these packs are "stripped" by removing and trading with other soldiers, those components that are unlikely to be consumed by the person carrying the pack. This also reduces the weight of the packs, allowing more to be carried. There are eight menu choices, one of which is vegetarian. None of them are allergen free since Defence Force members are typically selected, among many other attributes, for their no known allergy status. Combat Ration Five Man contains a similar array of components as the Combat Ration One Man.
Registered voters: 125,090 valid: 104,941 turnout: 84% The West Prussian plebiscite area remained with Germany and became part of the new West Prussia Government Region, which was annexed to East Prussia in 1922.
Rho factor A protein cofactor involved in signaling the termination of transcription in bacteria. Rho factor recognizes and binds a C-rich/G-poor terminator sequence in the nascent RNA transcript, which promotes dissociation of the transcriptional complex and release of the transcript from the DNA template. Other mechanisms of termination which do not require Rho factor also exist.
Sources: en.wikipedia.org
Master of Science, Master of Business Administration, Master of Health Administration, Doctor of medical laboratory science for specialization, education and management roles. Doctor of Philosophy for management and directorship roles in the clinical laboratory as well as for academic research and professorship. Doctors of Philosophy holding a degree in a biological science, and who are board certified by a CLIA-approved entity, are qualified as a medical laboratory director. Doctor of Medicine or Doctor of clinical laboratory Science - this is the position that qualifies an individual to oversee or direct almost all types of clinical laboratories. Under U.S. CLIA laws, a requirement of at least year of clinical laboratory experience (any MD) or pathology residency must be met. In the United Kingdom the Modernising Scientific Careers (MSC) programme sets out a training and career framework for the healthcare science workforce. One aspect of the framework was the formalisation of training to develop talented clinical scientists to undertake Higher Specialist Scientist Training (HSST) programmes to prepare them for roles as consultant clinical scientists. Training through the Higher Specialist Scientist Training pathway is discipline specific. For life science disciplines (immunology, microbiology, virology, haematology, biochemistry) the training curriculum and formal examinations are administered by the Royal College of Pathologists.
The fluorenylmethoxycarbonyl protecting group (Fmoc) is a base-labile amine protecting group used in organic synthesis, particularly in peptide synthesis. It is popular for its stability toward acids and hydrolysis and its selective removal by weak bases, such as piperidine, without affecting most other protecting groups or sensitive functional groups. Fmoc protection is especially advantageous in solid-phase peptide synthesis (SPPS), where its compatibility with other reagents and ease of removal streamline synthesis workflows. Upon deprotection, Fmoc yields a byproduct (Dibenzofulvene) that can be monitored by UV spectroscopy, allowing for efficient reaction tracking.
=== Pregnancy and breastfeeding === SSRI use in pregnancy has been associated with a variety of risks with varying degrees of proof of causation. As depression is independently associated with negative pregnancy outcomes, determining the extent to which observed associations between antidepressant use and specific adverse outcomes reflect a causative relationship has been difficult in some cases. In other cases, the attribution of adverse outcomes to antidepressant exposure seems fairly clear. SSRI use in pregnancy is associated with an increased risk of spontaneous abortion of about 1.7-fold. Use is also associated with preterm birth. According to some researches, decreased body weight of the child, intrauterine growth retardation, neonatal adaptive syndrome, and persistent pulmonary hypertension also was noted. A systematic review of the risk of major birth defects in antidepressant-exposed pregnancies found a small increase (3% to 24%) in the risk of major malformations and a risk of cardiovascular birth defects that did not differ from non-exposed pregnancies. Other studies have found an increased risk of cardiovascular birth defects among depressed mothers not undergoing SSRI treatment, suggesting the possibility of ascertainment bias, e.g. that worried mothers may pursue more aggressive testing of their infants. Another study found no increase in cardiovascular birth defects and a 27% increased risk of major malformations in SSRI-exposed pregnancies. The FDA stated on July 19, 2006, that nursing mothers on SSRIs must discuss treatment with their physicians.
Sources: en.wikipedia.org
It is a synthetic 39-amino-acid peptide that acts on two incretin receptors, the GIP receptor and the GLP-1 receptor. It is given by subcutaneous injection and has a circulating half-life of roughly five days. It is not a small molecule and is not absorbed usefully from the gut in conventional oral form.
Selective agents act on one receptor, while tirzepatide engages both GIP and GLP-1 receptors. The added GIP activity may contribute effects on insulin sensitivity and on fat metabolism. Whether the dual action produces meaningful clinical advantages beyond differences in potency is still being examined.
The downstream consequences of GIP receptor activation are not fully characterised in humans. It is also unclear how much each receptor contributes to appetite reduction and to shifts in body composition. Published work describes associations and proposed pathways rather than settled causal chains.
RP-HPLC is widely used for purity and impurity profiling. Mass spectrometry confirms identity.